TrivarX Limited (ASX:TRI)
Australia · Delayed Price · Currency is AUD 0.0210
+0.0010 (5.00%)
At close: Jan 22, 2026
TrivarX Market Cap
TrivarX has a market cap or net worth of 24.23 million as of January 22, 2026. Its market cap has increased by 225.73% in one year.
Market Cap
24.23M
Enterprise Value
23.15M
Revenue
1.03M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.02
Market Cap Chart
Since July 2, 2001, TrivarX's market cap has increased from 11.57M to 24.23M, an increase of 109.42%. That is a compound annual growth rate of 3.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 24.23M | 10.53% |
| Dec 31, 2025 | 21.92M | 194.71% |
| Dec 30, 2024 | 7.44M | -26.66% |
| Dec 29, 2023 | 10.14M | 52.72% |
| Dec 28, 2022 | 6.64M | -41.41% |
| Dec 30, 2021 | 11.34M | 5.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 85.10B |
| Pro Medicus | 19.76B |
| Cochlear | 17.57B |
| Sonic Healthcare | 11.40B |
| Ramsay Health Care | 8.43B |
| Ansell | 4.85B |
| Telix Pharmaceuticals | 3.82B |
| Mesoblast | 3.28B |